Drug Shortage Report for TEVA-TOPILENE

Last updated on 2025-03-20 History
Report ID 236356
Drug Identification Number 00849669
Brand name TEVA-TOPILENE
Common or Proper name TOPILENE 0.05% OINTMENT
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) BETAMETHASONE
Strength(s) 0.05%
Dosage form(s) OINTMENT
Route of administration TOPICAL TOPICAL
Packaging size 50g
ATC code D07AC
ATC description CORTICOSTEROIDS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-08-28
Estimated end date 2025-04-30
Actual end date
Shortage status Actual shortage
Updated date 2025-03-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2025-03-20 French Compare
v17 2025-03-20 English Compare
v16 2025-03-13 French Compare
v15 2025-03-13 English Compare
v14 2025-02-28 French Compare
v13 2025-02-28 English Compare
v12 2025-02-20 French Compare
v11 2025-02-20 English Compare
v10 2025-02-13 French Compare
v9 2025-02-13 English Compare
v8 2025-01-16 French Compare
v7 2025-01-16 English Compare
v6 2025-01-09 French Compare
v5 2025-01-09 English Compare
v4 2024-09-19 French Compare
v3 2024-09-19 English Compare
v2 2024-08-30 French Compare
v1 2024-08-30 English Compare

Showing 1 to 18 of 18